📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial. (2025)

First Author: Watson-Jones D

Attributed to: A Dose Reduction Immunobridging Study of two HPV vaccines in Tanzanian girls funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(24)00477-7

PubMed Identifier: 39890232

Publication URI: http://europepmc.org/abstract/MED/39890232

Type: Journal Article/Review

Volume: 13

Parent Publication: The Lancet. Global health

Issue: 2

ISSN: 2214-109X